• About
  • Contact
  • Privacy Policy
Mind And Body Tools
ADVERTISEMENT
  • Home
  • Psychology & Mental Health
  • Physical Health & Exercise
  • Nutrition & Diet
Newsletter
No Result
View All Result
HealthNews
No Result
View All Result
Home Physical Health & Exercise

The Adderall shortage in the US is expected to last for months

Mindandbodytools by Mindandbodytools
October 14, 2022
in Physical Health & Exercise
0
The Adderall shortage in the US is expected to last for months
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

TEva Pharmaceuticals Ltd’s Adderall shortage is expected to last through March, which is two to three months longer for the company. He said last weekaccording to US regulators.

A common treatment for attention-deficit/hyperactivity disorder has been unavailable since at least August, leaving people racing to fill prescriptions and find pharmacies with dodgy drugs in stock. Demand for the drug is at an all-time high, and Teva sells more Adderall in the United States than any other drug company.

Teva “Suffers Intermittent Delays in Manufacturing,” FDA He said on its website on Wednesday. While other companies are producing the drug, “there is not enough supply to continue to meet US market demand through these producers.”

Read more: For some women with ADHD, TikTok is the first place they have felt

Teva spokesman Kelly Dougherty said the company’s previous labor shortage, which has since been resolved, as well as increased drug demand and manufacturing limits set by the U.S. Drug Enforcement Administration have contributed to the shortage.

“We are working closely with our manufacturing facility and the DEA to see what additional volumes we may be able to support going forward,” Dougherty said.

Five doses of Teva’s generic immediate-release Adderall are on hold, with recovery expected in March, including the most popular 10mg, 20mg and 30mg pills, according to the Food and Drug Administration. Most Teva-branded immediate-release formulations are available, but 10 mg tablets are also in late demand, with recovery expected this month.

Nine companies in total have had trouble supplying Adderall lately.

The FDA lists three companies in addition to Teva that are in short supply — Epic Pharma LLC, Rhodes Pharmaceuticals LP (a subsidiary of Purdue Pharma LP), and SpecGX LLC (a subsidiary of Mallinckrodt Plc). Additionally, the University of Utah Drug Information Service, which tracks drug shortages, reported last week that Amneal Pharmaceuticals Inc. and Camber Pharmaceuticals Inc, Novartis AG’s Sandoz unit, Par Pharmaceutical (part of Endo International Plc), and Sun Pharmaceutical Industries Ltd. They were having trouble getting medicine.

More must-read stories from TIME


call us in letter@time.com.

Source link

Previous Post

Why Doctors Are Lying to You

Next Post

Zero FXE: The perfect start-up electric motorcycle

Mindandbodytools

Mindandbodytools

Next Post
Zero FXE: The perfect start-up electric motorcycle

Zero FXE: The perfect start-up electric motorcycle

Discussion about this post

No Result
View All Result

Popular Post

  • Shifting views about obsessive-compulsive disorder

    Shifting views about obsessive-compulsive disorder

    0 shares
    Share 0 Tweet 0
  • 6 groups that make mental health care accessible to BIPOC

    0 shares
    Share 0 Tweet 0
  • A Comprehensive Review Of Nutrition And Diet Therapy Quizlet

    0 shares
    Share 0 Tweet 0
  • 10 Quizlet Questions To Determine Your Nutrition And Diet Therapy Needs

    0 shares
    Share 0 Tweet 0
  • Is a vegetarian diet good for the elderly?

    0 shares
    Share 0 Tweet 0

Categories

  • Nutrition & Diet (529)
  • Physical Health & Exercise (2,003)
  • Psychology & Mental Health (381)
  • About
  • Contact
  • Privacy Policy

Copyright © 2022 Mindandbodytools.com

No Result
View All Result
  • Home
  • Psychology & Mental Health
  • Physical Health & Exercise
  • Nutrition & Diet

Copyright © 2022 Mindandbodytools.com